Clinical Trial Update: Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous platelet-rich plasma for hypertrophic burn scars has been terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Drugs mentioned

• Autologous Platelet-Rich Plasma (platelet-rich plasma)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Hypertrophic Scar | Phase 2 | Status: TERMINATED | Results posted: 2023-01-09